The Ophthalmic Devices Market To Flourish On The Continuous Basis
The Ophthalmic Devices Market Share is expected to reach US$ 42.68 Billion at a CAGR of
6.5% between 2021. With the WHO at the helm of universal health coverage, all the
communities across the globe are eligible to use curative, preventive, promotive, palliative,
and rehabilitative health services of proper quality. In other words, qualitative healthcare
would soon be the norm throughout.
A new-fangled norm is likely to be observed by the healthcare vertical going forward. In
other words, the novel healthcare vertical normal for supply chains, tech projects, governing
critical supplies, regulations, and resilience would be new frameworks built by inter-
governmental and governmental agencies for data sharing and response to disease. The
Ophthalmic Devices Market is there to move along the private and public collaborations and
According to a new market report published by Persistence Market Research “Global
Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020,” the global
ophthalmic devices market was valued at USD 29,171.5 million in 2014 and is expected to
grow at a CAGR of 6.5% from 2014 to 2020, to reach an estimated value of USD 42,685.1
million in 2020.
Globally, the ophthalmic devices market is witnessing significant growth due to increasing
prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In
addition, growing global aging population, increasing government initiatives towards
healthcare infrastructure in developing countries, and increasing incidence of lifestyle-
associated diseases are also driving the growth of the market.
Get Sample Copy of Report
Some of the major players in the global ophthalmic devices market:
Johnson & Johnson.
Bausch & Lomb Incorporated.
Abbott Laboratories, Inc.
Get To Know Methodo